Dr. Mario Barro is a leading vaccine research and development expert serving as the Associate Vice President, Head of Advanced Research at FluNXT/Sanofi Pasteur. Barro has led collaborative/networks/partnerships for influenza vaccine development with the CDC, FDA, NIH and NIBSC. His broad based scientific training includes physics, bioinformatics and biological sciences.

Barro has more than 25 years of experience leading discovery, preclinical and advance development programs in academic, government and private settings. He is a member in technical innovation evaluation panels, scientific committees for BARDA programs, NIH study sections, FDA regulatory science panels and World Health Organization. He has obtained external funding from federal (NIH, R01) and international organizations (WHO). Scientific reviewer for Vaccines, PLOS Pathogen, Clinical Virology and Journal of Virology. He also has experience working on new strategies developing adjuvants, vaccine platforms and diagnostic assays in Latin America (Cuba, Chile) and the US.

View his publications at ResearchGate.

View his LinkedIn profile.